Ken Fisher’s Opus Genetics IRD Stock Holding History

Ken Fisher’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-21	Closed	-$9K	–	572
2014 Q2	$9K	Buy	+21	New	+$9.55K	﹤0.01%	553

Other funds holding IRD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ken Fisher's IRD Position: Q3 2014 in Review

Ken Fisher sold out of Opus Genetics (IRD) in Q3 2014, closing a stake of 21 shares — an estimated $9K sold.

Ken Fisher first reported a position in IRD in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 31 funds tracked by Wall St. Rank hold IRD as of Q3 2014.

Ken Fisher reported no remaining Opus Genetics position as of Q3 2014 after selling out during the quarter.
Ken Fisher sold 21 Opus Genetics shares in Q3 2014, an estimated $9K.
Ken Fisher first reported a position in Opus Genetics in Q2 2014 and held it in 1 quarter.
Ken Fisher's Opus Genetics position peaked at $9K in Q2 2014.
31 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2014.

Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.